M Sillanpää1, D Schmidt2. 1. Departments of Child Neurology and Public Health, University of Turku and Turku University Hospital, Turku, Finland. 2. Epilepsy Research Group, Berlin, Germany.
Abstract
PURPOSE: To review the long-term outcome of epilepsy in population-based studies. METHOD: Analysis of population-based studies. RESULTS: About two of three patients with new-onset epilepsy will, in the long run, enter five-year terminal remission. Chances for remission are best for those with idiopathic or cryptogenic epilepsy. It is unclear whether the seizure outcome has improved over the last several decades. Social outcome, however, may have become better because of the improved level of knowledge on and public attitudes toward people with epilepsy, and possibly fewer prejudices at home, daycare, school, military and labor market. CONCLUSION: While we still do not have a cure for epilepsy for all patients, relief of the medical and social consequences is available for many and hope is on the horizon for people with epilepsy.
PURPOSE: To review the long-term outcome of epilepsy in population-based studies. METHOD: Analysis of population-based studies. RESULTS: About two of three patients with new-onset epilepsy will, in the long run, enter five-year terminal remission. Chances for remission are best for those with idiopathic or cryptogenic epilepsy. It is unclear whether the seizure outcome has improved over the last several decades. Social outcome, however, may have become better because of the improved level of knowledge on and public attitudes toward people with epilepsy, and possibly fewer prejudices at home, daycare, school, military and labor market. CONCLUSION: While we still do not have a cure for epilepsy for all patients, relief of the medical and social consequences is available for many and hope is on the horizon for people with epilepsy.
Authors: Nicholas S Phillips; Raja B Khan; Chenghong Li; Sedigheh Mirzaei Salehabadi; Tara M Brinkman; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull; Zsila S Sadighi Journal: Cancer Date: 2021-09-01 Impact factor: 6.860
Authors: Valérie Wester; Saskia de Groot; Tim Kanters; Louis Wagner; Jacqueline Ardesch; Isaac Corro Ramos; Marie-Jose Enders-Slegers; Martine de Ruiter; Saskia le Cessie; Jeanine Los; Grigorios Papageorgiou; Job van Exel; Matthijs Versteegh Journal: Front Neurol Date: 2020-01-22 Impact factor: 4.003
Authors: Klajdi Puka; Karen Bax; Andrea Andrade; Margo Devries-Rizzo; Hema Gangam; Simon Levin; Maryam N Nouri; Asuri N Prasad; Mary Secco; Guangyong Zou; Kathy N Speechley Journal: Trials Date: 2020-11-11 Impact factor: 2.279
Authors: David M Hughes; Laura J Bonnett; Gabriela Czanner; Arnošt Komárek; Anthony G Marson; Marta García-Fiñana Journal: Neurology Date: 2018-11-02 Impact factor: 9.910